Despite the FDA’s removal of Anavar like a treatment for muscle wasting, we find Anavar’s chance-to-reward ratio being much more favorable than Ostarine’s, as it might yield remarkable results when it comes to: Like all SARMs, Ostarine is marketed like a research chemical only.